Phase I pilot clinical trial of human IgM monoclonal antibody to ganglioside GM3 in patients with metastatic melanoma

By Irie Reiko   Ollila David   O’Day Steven   Morton Donald  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 2, 2004-02 ,pp. : 110-117

Springer Publishing Company

Access to resources Recommend Favorite

Identification of APN/CD13 as the target antigen of FU3, a human monoclonal antibody that recognizes malignant fibrous histiocytoma

By          

International Journal of Oncology, Vol. 43, Iss. 1, 2013-01 ,pp. : 57-62

Spandidos Publications

Access to resources Recommend Favorite

Construction and expression of a human/mouse chimeric CD19 monoclonal antibody: Successful modification of a murine IgM to a chimeric IgG

By        

Experimental and Therapeutic Medicine, Vol. 7, Iss. 4, 2014-01 ,pp. : 849-854

Spandidos Publications

Access to resources Recommend Favorite

Characterization of a novel mouse monoclonal antibody, clone 1E8.33, highly specific for human procollagen 11A1, a tumor-associated stromal component

By                    

International Journal of Oncology, Vol. 40, Iss. 5, 2012-01 ,pp. : 1447-1454

Spandidos Publications

Access to resources Recommend Favorite

Survival benefit associated with human anti-mouse antibody (HAMA) in patients with B-cell malignancies

By Azinovic Ignacio   DeNardo Gerald   Lamborn Kathleen   Mirick Gary   Goldstein Desiree   Bradt Bonnie   DeNardo Sally  

Cancer Immunology, Immunotherapy, Vol. 55, Iss. 12, 2006-12 ,pp. : 1451-1458

Springer Publishing Company

Access to resources Recommend Favorite